Wendy Stock to Pulmonary Veno-Occlusive Disease
This is a "connection" page, showing publications Wendy Stock has written about Pulmonary Veno-Occlusive Disease.
Connection Strength
0.041
-
Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study. Cancer. 2019 07 15; 125(14):2474-2487.
Score: 0.041